reports
American Express Co: 2 directors
Two Directors at American Express Co sold after exercising options/sold 6,733 shares at between 230.930USD and 232.360USD. The significance rating of the trade was 93/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by al...
Ionis Pharmaceuticals Inc: 1 director
A director at Ionis Pharmaceuticals Inc sold 6,000 shares at 42.713USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...
- ABGSC IT Research
- Ali Shemmari
- Petter Nystrøm
- ABGSC Oil & Oil Services Research
- John Olaisen
- Martin Mauseth
Aon plc: 1 director
A director at Aon plc bought 10,000 shares at 276.612USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Matson Inc: 1 director
A director at Matson Inc sold 2,800 shares at 112.481USD and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...
Caesars Entertainment Inc: 1 director
A director at Caesars Entertainment Inc bought 40,000 shares at 36.393USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Criteo SA: 1 director
A director at Criteo SA sold 21,661 shares at 37.122USD and the significance rating of the trade was 71/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
Coinbase Global Inc: 1 director
A director at Coinbase Global Inc sold 23,075 shares at 224.134USD and the significance rating of the trade was 99/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...
USANA Health Sciences Inc: 2 directors
Two Directors at USANA Health Sciences Inc sold after exercising options/sold 5,688 shares at between 44.589USD and 44.763USD. The significance rating of the trade was 78/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades b...
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a sl...
EQS-News: Carl Zeiss Meditec AG / Key word(s): Half Year Report/Half Year Results Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects 08.05.2024 / 06:26 CET/CEST The issuer is solely responsible for the content of this announcement. Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects Planned reduction of stocks of surgical consumables in the Chinese distribution channel successfully completed JENA, 8 May 2024 Carl Zeiss Meditec generated revenue of around ...
EQS-News: MPC Capital mit starkem ersten Quartal: Finanzkennzahlen unt...
EQS-News: MPC Münchmeyer Petersen Capital AG / Schlagwort(e): Quartals-/Zwischenmitteilung MPC Capital mit starkem ersten Quartal: Finanzkennzahlen unterstreichen hochprofitables Geschäftsmodell 08.05.2024 / 06:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Pressemitteilung MPC Capital mit starkem ersten Quartal: Finanzkennzahlen unterstreichen hochprofitables Geschäftsmodell Wiederkehrende Management Fees steigen um 4 %, Transaction Fees um 64 % Anstieg des EBT um 69 % auf EUR 7,0 Mio. durch starkes Transaktionsgeschäft und na...
EQS-News: MPC Capital with strong first quarter: Key financial figures...
EQS-News: MPC Münchmeyer Petersen Capital AG / Key word(s): Quarterly / Interim Statement MPC Capital with strong first quarter: Key financial figures underline highly profitable business model 08.05.2024 / 06:30 CET/CEST The issuer is solely responsible for the content of this announcement. Press Release MPC Capital with strong first quarter: Key financial figures underline highly profitable business model Recurring management fees increase by 4%, transaction fees by 64% EBT up 69% to EUR 7.0 million due to strong transaction business and sustained high returns from c...
EQS-News: Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit w...
EQS-News: Carl Zeiss Meditec AG / Schlagwort(e): Halbjahresbericht/Halbjahresergebnis Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab 08.05.2024 / 06:26 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Carl Zeiss Meditec schließt das erste Halbjahr 2023/24 mit währungsbedingt leicht rückläufigem Umsatz ab Planmäßiger Vorratsabbau von chirurgischen Verbrauchsmaterialien im chinesischen Vertriebskanal erfolgreich beendet JENA, 8. Mai 2024 Carl Zeiss Meditec erreichte in den e...
Mowi ASA (OSE: MOWI): Quarterly dividend
Mowi ASA (OSE: MOWI): Quarterly dividend The Board of Mowi ASA has resolved on 7 May 2024 to make a quarterly distribution to shareholders of NOK 1.50 per share. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded including dividend up to and including 15 May 2024. Mowi ASA’s shares listed on the Oslo Stock Exchange will be traded excluding dividend from and including 16 May 2024. Mowi ASA’s shares listed on the Oslo Stock Exchange will have a Record Date of 21 May 2024. The expected payment date is 28 May 2024. This information is subject to the disclosure requirements pur...
Mowi ASA (OSE: MOWI): Notice of Annual General Meeting 30 May 2024
Mowi ASA (OSE: MOWI): Notice of Annual General Meeting 30 May 2024 Mowi ASA’s Annual General Meeting will be held on 30 May 2024 at 11:00 CET as a digital meeting. The notice including agenda for the meeting and selected appendices are attached to this disclosure. The notice will be sent today to all shareholders. The notice with complete appendices will be made available on Mowi’s website, . This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment
Mowi ASA (OSE: MOWI): Innkalling til ordinær generalforsamling 30. mai...
Mowi ASA (OSE: MOWI): Innkalling til ordinær generalforsamling 30. mai 2024 Ordinær generalforsamling i Mowi ASA avholdes 30. mai 2024 kl. 11:00 som et digitalt møte. Innkalling med dagsorden til generalforsamlingen samt utvalgte vedlegg følger vedlagt. Innkallingen sendes i dag til alle aksjonærer. Innkallingen med samtlige vedlegg gjøres tilgjengelig på Mowis nettsider . Denne opplysningen er informasjonspliktig etter verdipapirhandelloven §5-12. Vedlegg
Jamf Holding Corp: 2 directors
Two Directors at Jamf Holding Corp sold 53,639 shares at between 20.033USD and 20.068USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Utz Brands Inc: 3 directors
Three Directors at Utz Brands Inc sold/sold after exercising options 70,106 shares at between 18.993USD and 19.469USD. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all th...
Heritage Insurance Holdings Inc: 2 directors
Two Directors at Heritage Insurance Holdings Inc bought 55,000 shares at between 8.110USD and 8.350USD. The significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.